InfaCare Pharmaceutical Corporation Raises $28 Million in Series B Financing to Advance Its Neonatal Pipeline
10/27/2008 8:19:24 AM
More...
|
InfaCare Pharmaceutical Corporation Appoints Dr. Ronald Dundore, Vice President Of Regulatory And Quality Affairs
10/16/2006 11:40:54 AM
More...
|
InfaCare Pharmaceutical Corporation Appoints Dr. Simon Tulloch, Chief Medical Officer
6/27/2006 2:47:48 PM
More...
|
InfaCare Pharmaceutical Corporation Announces Formation Of New Product Advisory Board
6/7/2006 12:55:49 PM
More...
|
InfaCare Pharmaceutical Corporation Raises $30 Million In Series A Financing
3/10/2006 5:08:23 PM
More...
|
InfaCare To Present At Wells Fargo Healthcare Forum
10/19/2005 5:12:49 PM
More...
|
WellSpring Pharmaceutical Corporation Receives FDA Clearance To Market Duvoid(R) Brand Of Bethanechol 50mg Strength
10/19/2005 5:12:36 PM
More...
|
InfaCare Names Ronald Goldfuss CFO
10/19/2005 5:12:33 PM
More...
|
InfaCare Names John R. Post President And CEO
10/19/2005 5:12:26 PM
More...
|
InfaCare Names John R. Post COO; Company Focus On Neonatal And Pediatric Therapeutics
10/19/2005 5:11:28 PM
More...
|
|